Palvella Therapeutics Wins Additional US FDA Grant Funding for Rare Skin Disease Drug

MT newswire2026/09/28 12:17

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

08:17 AM EDT, 09/28/2026 (MT Newswires) -- Palvella Therapeutics (PVLA) said Monday that it has received a third year of grant funding from the US Food and Drug Administration to support trials for its rare skin disease treatment. The funding supports the late-stage study and an ongoing extension study of Qtorin rapamycin for microcystic lymphatic malformations, the drug developer said. The award comes after the FDA reviewed Palvella's annual performance progress report, which included results from the late-stage trial, the company said. Palvella submitted a New Drug Application last month after the late-stage trial met all primary and secondary endpoints, the company said.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

October 5th – Elon Musk confirmed discussions with TSMC (2330.TW), prompting a 3% increase in the company’s share price. The Taiwan Stock Exchange Weighted Index (.TWII) rose by 2.4%. Tesla (TELA.O) and SpaceX (SPCX.O) CEO Musk stated on Saturday via X platform that TSMC and his chip manufacturing project, Terafab, have discussed potential collaboration. In response to a post on X featuring a screenshot of an article titled “TSMC is exploring plans to cooperate with Elon Musk’s TeraFab,” Musk replied on Saturday: "It is only at the discussion stage for now, but something could result." TSMC’s share price has increased by 66% so far this year. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. As automated translations may contain errors or lack needed context, Reuters does not guarantee the accuracy of the automated translated texts. They are provided merely for the convenience of readers. Reuters bears no responsibility for any damage or losses resulting from the use of the automated translation function.)

路透社•2026/10/05 02:16

10-Yr Benchmark Govt Yields - Germany vs Other Nations

Current Spread in Yield Basis Points Germany 3.475 % Australia 5.347 % 187.2 Belgium 4.339 % 86.4 Canada 3.944 % 46.9 Denmark 3.268 % -20.7 France 4.866 % 139.1 Italy 4.604 % 113.0 Japan 3.089 % -38.6 Netherlands 3.577 % 10.2 Spain 4.087 % 61.2 Sweden 3.146 % -32.9 U.K. 5.369 % 189.4 U.S. 5.256 % 178.1 Source: Tullett Prebon via FactSet (END) Dow Jones Newswires October 04, 2026 22:10 ET (02:10 GMT)

Dow Jones•2026/10/05 02:10

BoJ’s Uchida: AI has become a major focus among central banks, including at BoJ policy meetings

FXStreet•2026/10/05 01:51

Vanadium Redox Flow Energy Storage: Opportunities and Challenges of the New Cycle

华尔街见闻•2026/10/05 01:47